Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

17 avril 2018

05:00
L'Institut Marquès a participé à  l'Ig Nobel Tour en Suède et au Danemark en présentant ses travaux de recherche sur l'audition foetale et l'effet de la musique sur les toutes premières étapes de la vie    Depuis des années, l'Institut Marquès,...

02:45
New results from a Pfizer study on Ibrance® (palbociclib, Pfizer) of women with metastatic breast cancer demonstrate that DiviTum can provide fast evaluation of biologic effect demonstrating CDK 4/6 inhibition. The study, presented at the ongoing...


16 avril 2018

18:22
JHL Biotech announced today that the China Food and Drug Administration (CFDA) has accepted for review JHL's Clinical Trial Application for a proposed bevacizumab biosimilar, JHL1149, to treat cancer. JHL1149 is a...

16:35
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered dendritic cell cancer vaccines, today announced that new interim data from the ongoing Phase 2b clinical trial of the TLPLDC (tumor lysate, particle-loaded,...

16:15
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that it has entered a new worldwide collaboration with Bristol-Myers Squibb Company on a program to develop and commercialize Factor XIa (FXIa) inhibitors, including...

16:12
Six regional health systems today announce the founding of a nonprofit clinical research consortium ? Partners in Innovation, Education, and Research (PIER Consortiumtm) ? a streamlined clinical trial system that will span New Jersey and...

11:30
The Lustgarten Foundation for Pancreatic Cancer Research and Stand Up To Cancer (SU2C) announced Sunday at the Annual Meeting of the American Association for Cancer Research that they are entering into a formal strategic partnership to drive research...

11:25
RXi Pharmaceuticals Corporation , a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today that research conducted using its...

10:00
United Neuroscience, Ltd., (UNS), today announced that it has signed a collaboration agreement with the Lee Goldstein laboratory at the Boston University School of Medicine to investigate the potential of Endobody vaccines developed by United...

10:00
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the initiation of a Phase 2b clinical trial of GBR 830, a novel, investigational treatment for moderate-to-severe atopic dermatitis. The trial's primary endpoint will assess...

09:30
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the EGFR or ALK genes, when compared to chemotherapy alone,...

09:00
DelMar Pharmaceuticals, Inc. ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced four poster presentations being delivered at the American Association for...

09:00
Tocagen Inc. , a clinical-stage, cancer-selective gene therapy company, today reported preliminary data from the Toca 6 Phase 1 trial of Toca 511 & Toca FC in advanced solid tumors at the American Association for Cancer Research (AACR) Annual Meeting...

09:00
Trovagene, Inc. , a clinical-stage oncology therapeutics company, developing targeted therapeutics for the treatment of hematologic and solid tumor cancers, today announced the presentation of data showing that PCM-075 exhibits synergistic activity...

09:00
Genprex, Inc. , a clinical stage gene therapy company developing immunogene therapy for non-small cell lung cancer, today announced a clinical and corporate update.   Rodney Varner, Chairman and CEO, remarked, "2017 was...

09:00
VANCOUVER, B.C., April 16, 2018 /PRNewswire-PRWeb/ -- iData Research, a global leader in medical device market research, announced the release of a new study on the European market for soft tissue reinforcement and regeneration. This market analysis...

09:00
Ibex Medical Analytics, a pioneering developer of AI-powered cancer diagnostics, is announcing today that it has deployed the first ever AI-based digital pathology diagnostic system in a live clinical setting. Ibex's...

09:00
Aprea Therapeutics today presented results at the 2018 AACR Annual Meeting from its ongoing Phase Ib/II clinical study in MDS. The ongoing study, sponsored by the Moffitt Cancer Center with financial support from the Evans MDS Clinical Research...

08:35
OncoSec Medical Incorporated (OncoSec) , a company developing intratumoral cancer immunotherapies, today provided highlights from its Research Reception held on Sunday, April 15, 2018, during the American Association of Cancer Research (AACR) Annual...

08:00
FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide.     ...

08:00
Boehringer Ingelheim and Eli Lilly and Company today announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance® on the progression of kidney disease and the occurrence of cardiovascular death, in...

08:00
SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announces two new upcoming additions to the Seraseqtm Circulating Tumor DNA (ctDNA) portfolio of reference materials,...

08:00
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that data from a Phase 2 proof of concept clinical study of esketamine nasal spray, published in the American Journal of Psychiatry, showed that treatment with esketamine...

07:27
CureMatch, Inc. announces the presentation of new data showcasing advances in Precision Oncology at the American Association for Cancer Research (AACR) Annual Meeting in Chicago from April 14-18. The poster, titled 'Understanding tumor biology...

07:05
Ivantis Inc., developer of the novel Hydrus® Microstent, a device designed to lower eye pressure for open-angle glaucoma patients, announced today the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS).  Results from...

07:00
Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation committed to enabling the study of life-threatening human diseases, today announced the U.S. Food & Drug Administration (FDA) has exercised enforcement discretion in regard to the...

07:00
Esperance Pharmaceuticals Inc., a clinical stage company developing novel targeted membrane-disrupting peptides to treat cancer, today announced presentation of data on its lead investigational drug EP-100 at the American Association for Cancer...

06:49
Variant Pharmaceuticals, Inc. (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today receipt of FDA minutes from the March 12, 2018 Pre-IND meeting regarding development of VAR...

06:30
Sutro Biopharma's first antibody drug conjugate (ADC) to treat solid tumors was highly effective against ovarian cancer in preclinical xenograft models and had an encouraging safety profile, according to studies presented today in Chicago at the...

06:00
BioAtla, LLC, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics, announced today the U.S. Food and Drug Administration (FDA) has cleared BioAtla's Investigational New Drug...

03:30
Phase I data show early efficacy in the majority of patients and a very favourable safety profile Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting autoimmune diseases...

03:01
In a study of more than 15,000 girls and their mothers ? all Kaiser Permanente members in Northern California ? maternal overweight and hyperglycemia were linked to the earlier onset of puberty in girls 6 to 11 years old. Early puberty has been...

03:00
FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide.     ...

02:00
La Fédération dentaire internationale a publié deux ressources - un livre blanc et un guide pratique - dans le cadre de son Projet mondial de santé parodontale (GPHP - Global Periodontal Health Project), qui vise à attirer l'attention sur la santé...

01:17
Nordic Nanovector ASA (OSE: NANO) announces that a poster reporting the anti-tumour effect of Humalutin® (177Lu-conjugated humanized anti-CD37 antibody, 177Lu-NNV003) in preclinical models of non-Hodgkin's lymphoma (NHL) was presented yesterday at...


15 avril 2018

18:00
Nektar Therapeutics  today announced that it is presenting new preclinical data for its immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting 2018.  Nektar researchers and collaborators will present new...

09:35
Blueprint Medicines Corporation , a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the online publication of preclinical and clinical proof-of-concept data for BLU-667 in...

09:30
Blueprint Medicines Corporation , a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced proof-of-concept data from the ongoing Phase 1 ARROW clinical trial of BLU-667 in...


14 avril 2018

04:00
NGM Bio, a leading biotech company developing a portfolio of clinical-stage product candidates that modulate novel or previously intractable targets implicated in metabolic and other serious diseases, today announced data from a Phase 2 study of its...


13 avril 2018

16:56
One Drop's direct-to-consumer digital therapeutics solution lowers estimated A1c (eA1c) in people with type 2 diabetes by 1.90% in just 3 months. These findings were published in two peer-reviewed retrospective studies presented at the 39th Annual...

16:37
Taiho Oncology, Inc. today announced clinical data for LONSURF® (trifluridine and tipiracil, TAS-102) for the treatment of patients with advanced gastrointestinal tumors, and two investigational compounds, TAS-120 and TAS-114, both currently in...

16:15
Alcon, the global leader in eye care and a division of Novartis, launches the CyPass Ultra System designed to streamline the process of loading the CyPass Micro-Stent, a microinvasive glaucoma surgery (MIGS) device indicated for use in adult patients...

14:01
Franklin, Massachusetts based Arthrosurface, Inc. announced today the publication of mid-term data in the American Journal of Sports Medicine (AJSM), "Metal Resurfacing Inlay Implant for Osteochondral Talar Defects After Failed Previous Surgery: A...

10:44
Natera , a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, will present data demonstrating the ability of Signateratm (Research Use Only) to monitor treatment response, detect minimal residual disease, and...

10:00
TransMedics, Inc, une société de technologie médicale qui est un train de transformer l'importante thérapie de transplantation d'organes solides pour les patients atteints d'insuffisance pulmonaire, cardiaque et hépatique en phase terminale, a...

09:21
Kitov Pharma , today announced that TyrNovo Ltd., a company majority-owned by Kitov, will present pre-clinical data on TyrNovo's anti-tumor resistance drug candidate, NT219, in a poster session at the American Association for Cancer Research (AACR)...

08:07
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematologic and oncologic diseases, today announced the presentation of preclinical data supporting the apoptosis-inducing activity of alvocidib, a...

08:01
Allergan plc, , a leading global pharmaceutical company, today announced the official launch of TrueTear®, the first and only FDA-cleared device developed to temporarily increase tear production during neurostimulation in adult patients....

08:00
Menarini Ricerche will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor MEN1611, in development for solid tumors, at the AACR Annual Meeting 2018, which will take place on April 14-18, 2018, in...

03:00
Menarini Ricerche will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor MEN1611, in development for solid tumors, at the AACR Annual Meeting 2018, which will take place on April 14-18, 2018, in...